In total TI Pharma initiated 49 multilateral consortia working on projects ranging in size from EUR 2 to 18 million (over 4-5 years). TI Pharma has 28 academic partners: all Dutch universities and medical centers, and knowledge institutes like NKI and TNO and 45 industrial participants: half global companies, half small and medium sized enterprises.

Public partners
Academic Medical Center (AMC) Amsterdam
Centre for Human Drug Research 
Drugs for Neglected Diseases Initiative (DNDI)
Erasmus MC (University Medical Center Rotterdam)
Erasmus University Rotterdam
FIND - Foundation for Innovative New Diagnostics
Healthcare Insurance Board
Hubrecht Institute
Jan van Es Institute
Leiden University 
Leiden University Medical Center
Life Sciences & Health
Maastricht University 
Maastricht University Medical Center
Medicines Evaluation Board
Nefarma
Netherlands Cancer Institute
Netherlands Institute for Health Services Research (NIVEL)
Netherlands Institute for Neuroscience (NIN)
Netherlands Vaccine Institute 
Radboud University Nijmegen
Radboud University Nijmegen Medical Centre
Royal Tropical Institute (KIT)
TNO Quality of Life
University of Amsterdam
University of Bern
University Medical Center Groningen
University Medical Center Utrecht
University of Groningen
Utrecht University
VU University Amsterdam
VU University Medical Center
Wageningen University and Research Center  
ZonMW/Steering Committee on Orphan Drugs

Private partners
3D-PharmXchange
Abbott
Actelion
Aeon Astron Europe
Agamyxis
Agendia
Arcarios 
Astellas
Amgen
AstraZeneca
Batavia Bioservices 
Bio Detection Systems
Bioceros
BioFocus (a Galapagos company)
Biomade Technology
Biomarin
Bionovion
CardioGenx
Centocor
Danone Research
DC Prime
DSM Biomedical
Eli Lilly
Feyecon
Galapagos
GE Healthcare
Genzyme
GlaxoSmithKline
Glycostem Therapeutics
HQ Medical
InteRNA Technologies
IOTA Pharmaceuticals
IQ Corporation/IQ Therapeutics
ISA Pharmaceuticals
Isconova
Johnson & Johnson 
KNMP/WINap
Lead Pharma
LifeAssay Diagnostics
Lundbeck A/S
Madam Therapeutics
Magistro
Mercachem
Mymetics
MSD
Mucosis
NOTOX 
Nycomed
OctoPlus
PamGene
Pansynt
Pepscan Presto
Percuros
Pfizer
Pivot Park Screening Centre
PRA International
Prosensa Therapeutics
PROXY Laboratories
Sanaria
Sanofi Aventis
Shire
Syncom
Synvolux Therapeutics
TropIQ
UbiQ
Vaxinostics
Vertex Pharmaceuticals Incorporated
ViroClinics
Xendo

Other R&D public-private partnerships
Bio Medical Materials Program
Center for Translational Molecular Medicine
Dutch Polymer Institute 
Holst centre 
Life Sciences & Health cluster organization
Netherlands Institute for Metal Research 
Telematica Instituut 
Wageningen Centre for Food Sciences

Government
Ministry of Economic Affairs
Ministry of Education, Culture and Science
Ministry of Health, Welfare and Sport

“The experience that TI Pharma has from putting together partnerships to research neglected diseases is really valuable, because it applies across other therapeutic diseases.”

Share this page: